SAB4700564
Monoclonal Anti-Cd8a-APC antibody produced in rat
clone 53-6.7, purified immunoglobulin, buffered aqueous solution
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.41
UNSPSC Code:
12352203
Conjugate:
Allophycocyanin conjugate
Clone:
53-6.7, monoclonal
Application:
FACS
Citations:
3
biological source
rat
Quality Level
conjugate
Allophycocyanin conjugate
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
53-6.7, monoclonal
form
buffered aqueous solution
species reactivity
mouse
concentration
0.1 mg/mL
technique(s)
flow cytometry: suitable
isotype
IgG2a
NCBI accession no.
UniProt accession no.
shipped in
wet ice
storage temp.
2-8°C
target post-translational modification
unmodified
Gene Information
mouse ... Cd86(12524)
General description
The rat monoclonal antibody 53-6.7 recognizes mouse CD8a (32-34 kDa; alpha chain of the CD8 antigen).
Immunogen
Mouse spleen cells
Application
The reagent is designed for Flow Cytometry analysis. Suggested working dilution is 3 μg/mL of sample. Indicated dilution is recommended starting point for use of this product. Working concentrations should be determined by the investigator.
Features and Benefits
Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.
Physical form
Solution in phosphate buffered saline containing 15 mM sodium azide and 0.2% high-grade protease free BSA as a stabilizing agent.
Still not finding the right product?
Try our Product Selector Tool to narrow your options
Storage Class
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
常规特殊物品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Cheng-Zhong Li et al.
World journal of gastroenterology, 20(28), 9486-9496 (2014-07-30)
To determine the relationship between host immunity and the characteristics of viral infection or nucleoside analogues (NAs) themselves in patients with chronic hepatitis B (CHB) receiving NA therapy. Fifty-two hepatitis B envelope antigen (HBeAg) positive CHB patients were enrolled and
Hiroshi Mochimaru et al.
Investigative ophthalmology & visual science, 49(5), 2172-2177 (2008-02-12)
To investigate whether the induction of cytotoxic T lymphocytes (CTLs) targeting VEGF receptor 2 inhibits corneal neovascularization caused by alkali injury. H-2Db-restricted peptide corresponding to amino acids 400 to 408 of VEGF receptor 2 (VEGFR2(400-408)) was used as an epitope
Arta M Monjazeb et al.
PloS one, 9(8), e102709-e102709 (2014-08-15)
We have previously demonstrated that immunotherapy combining agonistic anti-CD40 and IL-2 (IT) results in synergistic anti-tumor effects. IT induces expansion of highly cytolytic, antigen-independent "bystander-activated" (CD8(+)CD44high) T cells displaying a CD25(-)NKG2D(+) phenotype in a cytokine dependent manner, which were responsible
Global Trade Item Number
| SKU | GTIN |
|---|---|
| SAB4700564-100UG | 04061829672706 |